© 1993 Oxford University Press
RESEARCH-ARTICLE |
Myotonic dystrophy kinase is a component of neuromuscular junctions
Department of Cell Biology and Histology, Medical Faculty University Nijmegen, Tngon Building PO Box 9101, 6500 HB Nijmegen 1Department of Biochemistry, Medical Faculty University Nijmegen, Trigon Building Nijmegen, The Netherlands 2Division of Cardiology, University of Colorado Health Science Center Denver, CO 80262 3Departments of Cellular and Structural Biology and Physiology and the Neuroscience Program, University of Colorado Health Science Centre Denver, CO 80262 4Department of Neurology, Baylor College of Medicine Houston, TX 77030, USA 5Department of Neurology, Medical Faculty University Nijmegen, Radbound Hospital Nijmegen, The Netherlands
*To whom correspondence should be addressed
Received June 21, 1993; Revised August 25, 1993; Accepted August 25, 1993
The clinical manifestation of myotonic dystrophy (DM) is correlated to the extent of expansion of an unstable [CTG]n DNA motif. Recent studies have demonstrated that this trinucleotide motif forms part of the last, 3' untranslated exon of a gene which potentially encodes multiple protein Isoforms of a serine/threonine protein klnase (myotonic dystrophy protein kinase, DM-PK). We report here on the development of antisera against synthetic DM-PK peptide antigens and their use In blochemical and histochemlcal studies. Immunoreactlve DM-kinase protein of 53 kD is present at low levels In skeletal and cardiac muscle extracts of DM patients and normal controls. Immunohlstochemical staining revealed that DM-PK Is localised prominently at sites of neuromuscular and myotendinous junctions (NMJs and MTJs) of human and rodent skeletal muscles. Furthermore, very low levels of Immunoreactive DM-PK protein are present in the sarcoplasm of predominantly type I fibres in various muscles. Strikingly, presence of the protein can also be demonstrated for NMJs of muscular tissues of adult and congenital cases of DM, with no gross changes In structural organisation. Our findings provide a basis for further characterisation of the role of the kinase in protein assembly processes or signal mediation at synaptic sites and ultimately for the understanding of the complex pathophysiology of DM.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Jiang, A. Mankodi, M. S. Swanson, R. T. Moxley, and C. A. Thornton Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons Hum. Mol. Genet., December 15, 2004; 13(24): 3079 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Furling, L. T. Lam, O. Agbulut, G. S. Butler-Browne, and G. E. Morris Changes in Myotonic Dystrophy Protein Kinase Levels and Muscle Development in Congenital Myotonic Dystrophy Am. J. Pathol., March 1, 2003; 162(3): 1001 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.T. Lam, Y.C.N. Pham, N. t. Man, and G.E. Morris Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart Hum. Mol. Genet., September 1, 2000; 9(14): 2167 - 2173. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J.T.A. Groenen, D. G. Wansink, M. Coerwinkel, W. van den Broek, G. Jansen, and B. Wieringa Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties Hum. Mol. Genet., March 1, 2000; 9(4): 605 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mussini, D. Biral, O. Marin, S. Furlan, and S. Salvatori Myotonic Dystrophy Protein Kinase Expressed in Rat Cardiac Muscle Is Associated with Sarcoplasmic Reticulum and Gap Junctions J. Histochem. Cytochem., March 1, 1999; 47(3): 383 - 392. [Abstract] [Full Text] |
||||
![]() |
L. A. Sabourin, K. Tamai, M. A. Narang, and R. G. Korneluk Overexpression of 3'-Untranslated Region of the Myotonic Dystrophy Kinase cDNA Inhibits Myoblast Differentiation in Vitro J. Biol. Chem., November 21, 1997; 272(47): 29626 - 29635. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Waring, R. Haq, K. Tamai, L. A. Sabourin, J.-E Ikeda, and R. G. Korneluk Investigation of Myotonic Dystrophy Kinase Isoform Translocation and Membrane Association J. Biol. Chem., June 21, 1996; 271(25): 15187 - 15193. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.T. Caskey, M.S. Swanson, and L.T. Timchenko Myotonic Dystrophy: Discussion of Molecular Mechanism Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 607 - 614. [Abstract] [PDF] |
||||
![]() |
L. S. Tokgozoglu, T. Ashizawa, A. Pacifico, R. M. Armstrong, H. F. Epstein, and W. A. Zoghbi Cardiac Involvement in a Large Kindred With Myotonic Dystrophy: Quantitative Assessment and Relation to Size of CTG Repeat Expansion JAMA, September 13, 1995; 274(10): 813 - 819. [Abstract] [PDF] |
||||
![]() |
M. Maeda, C. S. Taft, E. W. Bush, E. Holder, W. M. Bailey, H. Neville, M. B. Perryman, and R. D. Bies Identification, Tissue-specific Expression, and Subcellular Localization of the 80- and 71-kDa Forms of Myotonic Dystrophy Kinase Protein J. Biol. Chem., September 1, 1995; 270(35): 20246 - 20249. [Abstract] [Full Text] [PDF] |
||||





